Identifying new drug candidates using genome sequences
19 February, 2014A new technique is using computational approaches to identify optimal drug targets by mining a database of drug-RNA sequence interactions against thousands of cellular RNA sequences.
SSI Ultraflux i PCR strip tubes
17 February, 2014 | Supplied by: Interpath Services Pty LtdSSI Ultraflux i PCR strip tubes enable users to amplify their results. The tubes' ultrathin walls ensure efficient thermal transfer for maximum yield and clear results.
Genea Biocells becomes largest provider of human embryonic stem cells
17 February, 2014Australian stem cell company Genea Biocells has become the world’s largest provider of human embryonic stem cell (hESC) lines on the USA National Institutes of Health (NIH) Stem Cell Registry.
An interactive map of human genetic history
14 February, 2014Researchers have produced a global map detailing the genetic histories of 95 different populations across the world, spanning the last 4000 years.
Qiagen REPLI-g WTA Single Cell Kit and REPLI-g Cell WGA & WTA Kit
13 February, 2014 | Supplied by: QIAGEN Pty LtdThe REPLI-g WTA Single Cell Kit and REPLI-g Cell WGA & WTA Kit enable transcriptomic NGS analysis from single cells and comparative genomic and transcriptomic analysis from the same small sample.
Qiagen GeneRead DNA FFPE Kit
13 February, 2014 | Supplied by: QIAGEN Pty LtdThe GeneRead DNA FFPE Kit provides a streamlined, easy-to-use procedure for efficient purification of DNA from formalin-fixed, paraffin-embedded (FFPE) tissue sections.
NHS awards cytogenetics tender to OGT
10 February, 2014Oxford Gene Technology (OGT), a provider of innovative genetics research and biomarker solutions to advance molecular medicine, has been awarded a tender by the UK National Health Service (NHS) for the supply of oligo-based arrays for cytogenetics.
Capturing circulating cancer cells
06 February, 2014Researchers at the Ian Wark Research Institute, located at the University of South Australia, have developed a new way to catch cancer cells circulating in a patient's blood.
Biomedica NT-proBNP ELISA for determination of heart failure
31 January, 2014 | Supplied by: United Bioresearch Products Pty LtdNT-proBNP brain natriuretic peptide, a member of the cardiac natriuretic hormones (CNHs) family, is secreted by the hemodynamically stressed heart, mainly in response to myocardial stretch induced by volume overload. The NT-proBNP ELISA from Biomedica provides reproducible results with an easy-to-use, convenient 96-well protocol (5 standards, 1 control).
Qiagen submits C. difficile assay to FDA
30 January, 2014Qiagen plans to roll out a portfolio of assays for the QIAsymphony platform to aid in the diagnosis of healthcare-associated infections (HAIs). The company's first new test, the artus C. difficile QS-RGQ MDx Kit, has been submitted to the US Food and Drug Administration (FDA).
Sartorius Microsart AMP Mycoplasma Kit
27 January, 2014 | Supplied by: Sartorius Australia Pty LtdThere are many methods for the identification of a mycoplasma contamination. PCR-based detection kits such as the Microsart AMP Mycoplasma Kit from Sartorius offer users a sensitive and robust detection within only 3 h.
Qiagen and Exosome Diagnostics to develop diagnostics for genetic biomarkers in cancers
21 January, 2014Qiagen and Exosome Diagnostics have expanded their strategic partnership to develop non-invasive, in-vitro molecular diagnostics for detecting and monitoring actionable genetic mutations in lung-cancer patients.
The $1000 genome
16 January, 2014Sydney's Garvan Institute of Medical Research has been chosen as one of the first facilities in the world to acquire machines that can sequence a whole human genome at a base cost below US$1000.
DiaSorin offers free DNA extraction kits during February
16 January, 2014With each DiaSorin Liaison Ixt/Arrow instrument purchased during February 2014, the company is providing over $3000 worth of LIAISON Ixt/Arrow Stool DNA extraction kits free of charge.
Collaboration on the role of microRNAs in neurodegenerative disease
14 January, 2014Dutch biopharma InteRNA Technologies has entered into a collaborative agreement with two partners from the Neuroallianz Consortium - UCB Pharma and the Rheinish Friedrich-Wilhelms-University of Bonn - to support the investigation of microRNAs (miRNAs) in neurodegenerative diseases.
